Health Care/Hospital

MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA

GENEVA, May 5, 2023 /PRNewswire/ -- The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr.Arthur Lee at the Cardiac & Vascular Institute inFlorida. This study evaluates SELUTION SLR™ in the treatment of occlusive disease of the superficial femoral artery (SFA) and p...

2023-05-05 08:00 3028

SNIPR Biome's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology

* SNIPR001 is a novel CRISPR-Cas therapeutic designed to selectively target antibiotic resistantE. coli, which can cause fatal infections in vulnerable hematological cancer patients             * SNIPR001 represents the first CRISPR- therapeutic developed to specifically removeE. coli in the ...

2023-05-05 00:52 2571

National Comprehensive Cancer Network Honors Cancer Leaders who Guide the Future of Care

Theresa J. Franco, Fred & Pamela Buffett Cancer Center; F. Marc Stewart, City of Hope National Medical Center;Douglas E. Wood, UW Medicine Fred Hutchinson Cancer Center; andDonna Powell, NCCN, presented with awards during NCCN 2023 Annual Conference. PLYMOUTH MEETING, Pa., May 4, 2023 /PRNewswir...

2023-05-04 23:00 2514

ANGUS ANNOUNCES CORPORATE REBRANDING, WILL CHANGE NAME TO "ADVANCION"

New name and brand reflect Company's strategic transformation into a leading global producer of specialty ingredients for Life Sciences, Personal Care and other essential markets BUFFALO GROVE, Ill., May 4, 2023 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company") today unveiled a new n...

2023-05-04 21:00 3328

Cambridge Infinitus Research Centre Launches World Leading AI-based Technology Platform ERnet for Studies of Cellular Health

GUANGZHOU, China, May 4, 2023 /PRNewswire/ -- The Cambridge Infinitus Research Centre (CIRCE) was officially established in 2015 as Infinitus' first international scientific research collaboration platform outside ofChina. CIRCE recently achieved another scientific and technological breakthrough ...

2023-05-04 16:00 2272

First Subject Enrolled in Boan Biotech's International Multi-Center Phase 3 Clinical Study for Its Denosumab BA6101 & BA1102

YANTAI, China, May 4, 2023 /PRNewswire/ -- Boan Biotech today announced that an international multi-center Phase 3 clinical study for its in-house developed Denosumab Injection (BA6101; BA1102) has been initiated inEurope, the United States, and Japan, and recently the first patient in (FPI) was ...

2023-05-04 14:40 3663

European Wellness Joint Research with Heidelberg University in Journal Publication

HEIDELBERG, Germany, May 4, 2023 /PRNewswire/ -- European Wellness Academy (EWA), a wholly owned subsidiary European Wellness Biomedical Group (EW Group) has entered into a cooperation agreement with Heidelberg University in medical research. The research project, titled "A Tendon Specific Double...

2023-05-04 13:39 2167

George Clinical Applauded by Frost & Sullivan for Its Competitive Differentiation and Leadership in Strategy Execution in the Asia Pacific region

George Clinical cares for its employees, enables business continuity, and builds on its expertise, giving it a competitive industry advantage. SAN ANTONIO, May 4, 2023 /PRNewswire/ -- Frost & Sullivan studied the contract research organization industry and, based on its findings, recognizes Georg...

2023-05-04 11:00 1900

Annalise.ai grows global footprint with expansion into India

Leading global AI radiology company opens new office in Chennai CHENNAI, India, May 4, 2023 /PRNewswire/ -- Annalise.ai, one of the world's largest artificial intelligence (AI) radiology companies, has today announced it is continuing its global expansion with the opening of the Annalise India ...

2023-05-04 10:56 2418

Alma Lasers' Global Expansion and Vision for Holistic Wellness Solutions Unveiled at Fifth 'Alma Academy' in Italy, Attended by Physicians from 46 Countries

CAESAREA, Israel, May 4, 2023 /PRNewswire/ -- Alma Lasers , a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, is excited to announce the successful opening of the fifth Alma Academy. Nearly 500 physicians from 46 countries ...

2023-05-04 07:22 2327

Formus Labs, Pioneering Developer of AI-Powered 3D Orthopedic Surgery Planning Technology, Receives FDA Clearance

Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D surgical plans that optimize the preoperative (pre-op) planning process WARSAW, Ind., May 4, 2023 /PRNewswire/ -- Formus Labs today announced it has received 510(k) clearance from the United States Food ...

2023-05-04 06:18 1990

Aktiia's Continual Blood Pressure Solution Shows Comparable Results to ABPM

NEUCHÂTEL, Switzerland, May 4, 2023 /PRNewswire/ -- Aktiia, a health tech startup transforming hypertension care, has announced promising results from a preliminary study comparing their cuff-less and continual blood pressure monitor with traditional ambulatory blood pressure monitors (ABPM). The...

2023-05-04 00:00 2254

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

ZUG, Switerland, May 3, 2023 /PRNewswire/ -- SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for infl...

2023-05-03 22:43 2521

Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic™ Clinical Trial

BELTSVILLE, Md., May 3, 2023 /PRNewswire/ -- Reprocell USA, a CRO, has been awarded a contract to provide support for Lantern Pharma's Phase 2 clinical trial entitled "A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers with Advanced Lung Adenocarcinoma (HARMONIC)". The Harmonic™ s...

2023-05-03 21:00 2031

Healthcare Veteran, Zach Henderson to lead Global Kinetics as CEO

CHARLOTTE, N.C. and MELBOURNE, Australia, May 3, 2023 /PRNewswire/ -- Global Kinetics, the global leader in digital health solutions for neurological conditions, today announced the appointment of Zach Henderson as its new Chief Executive Officer. Zach will also join the Board of Directors.   Za...

2023-05-03 21:00 2114

LenioBio GmbH Announces New CEO

DUSSELDORF, Germany, May 3, 2023 /PRNewswire/ -- LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr.Remberto Martis, will be stepping down as CEO and has proudly named his successor as André Goerke, startingJune 1st, 2023.   Andr...

2023-05-03 20:00 2369

Frost & Sullivan Institute Announces the Launch of the 2023 Enlightened Growth Leadership Awards for Emerging Companies to Recognize Companies Driving a Sustainable Future

SANTA CLARA, Calif., May 3, 2023 /PRNewswire/ -- Frost & Sullivan Institute, in partnership with Frost & Sullivan announces the launch of the Enlightened Growth Leadership Awards, 2023 – Emerging Companies* edition. The award recognizes emerging companies that drive transformation toward a sustai...

2023-05-03 17:43 1848

Procter & Gamble commits to new actions and shares strong progress on commitments to promote Equality and Inclusion across the Asia Pacific, the Middle East, and Africa

The company announced new commitments at the P&G #WeSeeEqual summit that saw participation from international equality & inclusion advocates like Eddie Ndopu,Sarah Harden, Chieko Asakawa, and Elissa Frieha, among others SINGAPORE, May 3, 2023 /PRNewswire/ -- Procter & Gamble (NYSE: PG) today ann...

2023-05-03 16:13 3510

Chula Researchers Develop Rapid MTB Strip Test for Tuberculosis

Lecturers of the Faculty of Allied Health Sciences, Chulalongkorn University have developed the MTB Strip Test Kit for Tuberculosis (TB) diagnosis that's accurate and easy to use, guaranteed by the 2023 Invention Award from the National Research Council of Thailand (NRCT) -- Another hope to reduce...

2023-05-03 11:34 3022

Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea

* MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem * Proposed bioprocessing facility to be based in Daejeon City * Further collaboration aims to support emerging biotech companies and academic research DAEJEON CITY, South Korea, May 3, 2023 /PRNe...

2023-05-03 10:00 3109
1 ... 100101102103104105106 ... 554